Utah Medical Products, Inc.

Historical 13F Holders

Symbol
UTMD
CUSIP
917488108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 917488108 since 12/18/2024, newest first.

Filer % of Class Filed
Brandes Investment Partners, LP 13G/A Amendment 4
14.9% 8/14/2026
Event 6/30/2026
Renaissance Technologies LLC 13G/A Amendment 8
5.5% 8/13/2026
Event 6/30/2026
Brandes Investment Partners, LP 13G/A Amendment 3 14.1% 5/14/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 2 0% 3/27/2026
Event 3/13/2026
Brandes Investment Partners, LP 13G/A Amendment 2 10.4% 9/5/2025
Event 8/31/2025
Brandes Investment Partners, LP 13G/A Amendment 1 8.4% 8/12/2025
Event 6/30/2025
BlackRock, Inc. 13G 5.3% 7/17/2025
Event 6/30/2025
Dimensional Fund Advisors LP 13G/A Amendment 1 6.1% 7/15/2025
Event 6/30/2025
Brandes Investment Partners, LP 13G 7.4% 5/14/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 5 4.97% 2/5/2025
Event 12/31/2024
FMR LLC 13G/A Amendment 26
2.7% 1/8/2025
Event 12/31/2024
Renaissance Technologies LLC 13G/A Amendment 7
6.7% 11/13/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 1.05 k $77.6 k
2026 Q2 117 2.32 M $160 M
2026 Q1 121 2.27 M $140 M
2025 Q4 118 2.10 M $118 M
2025 Q3 120 2.18 M $137 M
2025 Q2 114 2.17 M $124 M
2025 Q1 111 2.24 M $126 M
2024 Q4 114 2.31 M $142 M
2024 Q3 113 2.48 M $166 M
2024 Q2 106 2.52 M $169 M
2024 Q1 105 2.66 M $189 M
2023 Q4 94 2.63 M $221 M
2023 Q3 96 2.58 M $222 M
2023 Q2 92 2.55 M $237 M
2023 Q1 90 2.55 M $242 M
2022 Q4 85 2.62 M $263 M
2022 Q3 79 2.54 M $216 M
2022 Q2 76 2.56 M $220 M
2022 Q1 87 2.57 M $231 M
2021 Q4 81 2.61 M $261 M
2021 Q3 73 2.60 M $242 M
2021 Q2 69 2.60 M $221 M
2021 Q1 80 2.63 M $228 M
2020 Q4 79 2.78 M $235 M
2020 Q3 86 2.65 M $212 M
2020 Q2 94 2.69 M $238 M
2020 Q1 92 2.63 M $247 M
2019 Q4 98 2.82 M $304 M
2019 Q3 99 2.85 M $273 M
2019 Q2 99 2.76 M $266 M
2019 Q1 96 2.73 M $242 M
2018 Q4 90 2.78 M $233 M
2018 Q3 95 2.81 M $265 M
2018 Q2 93 2.60 M $286 M
2018 Q1 82 2.60 M $257 M
2017 Q4 78 2.50 M $203 M
2017 Q3 74 2.48 M $182 M
2017 Q2 76 2.48 M $179 M
2017 Q1 78 2.44 M $152 M
2016 Q4 76 2.50 M $182 M
2016 Q3 79 2.50 M $150 M
2016 Q2 76 2.52 M $159 M
2016 Q1 68 2.56 M $160 M
2015 Q4 66 2.53 M $148 M
2015 Q3 59 2.47 M $133 M
2015 Q2 63 2.47 M $147 M
2015 Q1 62 2.41 M $146 M
2014 Q4 60 2.47 M $149 M
2014 Q3 63 2.21 M $108 M
2014 Q2 64 2.45 M $126 M
2014 Q1 59 2.40 M $139 M